Coloplast A/S (COLO-B) - Total Assets

Latest as of December 2025: Dkr48.80 Billion DKK ≈ $7.63 Billion USD

Based on the latest financial reports, Coloplast A/S (COLO-B) holds total assets worth Dkr48.80 Billion DKK (≈ $7.63 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Coloplast A/S book value and equity for net asset value and shareholders' equity analysis.

Coloplast A/S - Total Assets Trend (2002–2025)

This chart illustrates how Coloplast A/S's total assets have evolved over time, based on quarterly financial data.

Coloplast A/S - Asset Composition Analysis

Current Asset Composition (September 2025)

Coloplast A/S's total assets of Dkr48.80 Billion consist of 21.6% current assets and 78.4% non-current assets.

Asset Category	Amount (DKK)	% of Total Assets
Cash & Equivalents	Dkr0.00	2.0%
Accounts Receivable	Dkr5.18 Billion	10.7%
Inventory	Dkr3.92 Billion	8.1%
Property, Plant & Equipment	Dkr0.00	0.0%
Intangible Assets	Dkr10.48 Billion	21.7%
Goodwill	Dkr19.33 Billion	40.0%

Asset Composition Trend (2002–2025)

This chart illustrates how Coloplast A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Coloplast A/S market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Coloplast A/S's current assets represent 21.6% of total assets in 2025, a decrease from 58.1% in 2002.
Cash Position: Cash and equivalents constituted 2.0% of total assets in 2025, down from 7.1% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 0.0% in 2002.
Asset Diversification: The largest asset category is goodwill at 40.0% of total assets.

Coloplast A/S Competitors by Total Assets

Key competitors of Coloplast A/S based on total assets are shown below.

Company	Country	Total Assets
Alcon AG SW:ALC	Switzerland	CHF31.53 Billion
iRay Technology Co Ltd SHG:688301	China	CN¥11.33 Billion
Shenyang Xingqi Pharmaceutical Co Ltd SHE:300573	China	CN¥2.42 Billion
Anbio Biotechnology Class A Ordinary Shares NASDAQ:NNNN	USA	$32.49 Million
Jiangsu Nanfang Medical SHG:603880	China	CN¥993.46 Million
SDI Ltd AU:SDI	Australia	AU$141.20 Million
MEDIMI AB AK F:79T	Germany	€1.70 Million
I.Ceram SA PA:ALICR	France	€3.91 Million

Coloplast A/S - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.30	0.81	0.98
Quick Ratio	0.81	0.52	0.65
Cash Ratio	0.00	0.00	0.00
Working Capital	Dkr2.37 Billion	Dkr-2.40 Billion	Dkr-115.00 Million

Coloplast A/S - Advanced Valuation Insights

This section examines the relationship between Coloplast A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	7.76
Latest Market Cap to Assets Ratio	0.27
Asset Growth Rate (YoY)	0.6%
Total Assets	Dkr48.37 Billion
Market Capitalization	$13.07 Billion USD

Valuation Analysis

Below Book Valuation: The market values Coloplast A/S's assets below their book value (0.27x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Coloplast A/S's assets grew by 0.6% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Coloplast A/S (2002–2025)

The table below shows the annual total assets of Coloplast A/S from 2002 to 2025.

Year	Total Assets	Change
2025-09-30	Dkr48.37 Billion ≈ $7.57 Billion	+0.61%
2024-09-30	Dkr48.07 Billion ≈ $7.52 Billion	-0.18%
2023-09-30	Dkr48.16 Billion ≈ $7.53 Billion	+37.77%
2022-09-30	Dkr34.96 Billion ≈ $5.47 Billion	+120.67%
2021-09-30	Dkr15.84 Billion ≈ $2.48 Billion	+17.35%
2020-09-30	Dkr13.50 Billion ≈ $2.11 Billion	+6.02%
2019-09-30	Dkr12.73 Billion ≈ $1.99 Billion	+8.18%
2018-09-30	Dkr11.77 Billion ≈ $1.84 Billion	-2.33%
2017-09-30	Dkr12.05 Billion ≈ $1.89 Billion	+9.48%
2016-09-30	Dkr11.01 Billion ≈ $1.72 Billion	+1.76%
2015-09-30	Dkr10.82 Billion ≈ $1.69 Billion	+4.22%
2014-09-30	Dkr10.38 Billion ≈ $1.62 Billion	+10.84%
2013-09-30	Dkr9.36 Billion ≈ $1.47 Billion	-7.98%
2012-09-30	Dkr10.18 Billion ≈ $1.59 Billion	+10.39%
2011-09-30	Dkr9.22 Billion ≈ $1.44 Billion	+18.62%
2010-09-30	Dkr7.77 Billion ≈ $1.22 Billion	-2.41%
2009-09-30	Dkr7.96 Billion ≈ $1.25 Billion	-0.23%
2008-09-30	Dkr7.98 Billion ≈ $1.25 Billion	+2.98%
2007-09-30	Dkr7.75 Billion ≈ $1.21 Billion	-2.91%
2006-09-30	Dkr7.98 Billion ≈ $1.25 Billion	+34.95%
2005-09-30	Dkr5.92 Billion ≈ $925.44 Million	+4.86%
2004-09-30	Dkr5.64 Billion ≈ $882.53 Million	+5.24%
2003-09-30	Dkr5.36 Billion ≈ $838.61 Million	+19.40%
2002-09-30	Dkr4.49 Billion ≈ $702.34 Million	--

About Coloplast A/S

CO:COLO-B Denmark Medical Instruments & Supplies

Market Cap

$13.07 Billion

Dkr83.53 Billion DKK

Market Cap Rank

#1805 Global

#11 in Denmark

Share Price

Dkr402.80

Change (1 day)

+2.26%

52-Week Range

Dkr393.90 - Dkr696.00

All Time High

Dkr1106.54